Fungal Central Nervous System Infections in Patients With COVID-19
International Clinical Neuroscience Journal,
Vol. 8 No. 4 (2021),
30 October 2021
,
Page 154-156
Abstract
Recent studies have indicated that fungal co-infections have a major impact on the morbidity and mortality of patients with COVID-19. In these patients, the excessive production of inflammatory cytokines and the reduction in CD4 + T and CD8 + T cell count entails susceptibility to fungal infections.1 In addition to impaired cell-mediated immunity, comorbidities and immunosuppressive medications have a significant role in the development of fungal infections and have serious impacts on clinical outcomes.1-3
- CNS
- Fungal
- COVID-19
How to Cite
References
Tilavberdiev SA, Madaminov FA. Associated fungal infections, related to the global COVID-19 pandemic (literature review). International Journal of Multicultural and Multireligious Understanding. 2021;8(5):619-27.
Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for COVID-19 severity. Rev Saude Publica. 2020;54:60. doi: 10.11606/s1518- 8787.2020054002481.
Lotfali E, Ghasemi R, Mardani M, Fattahi A, Rezaei K, Toreyhi H, et al. A review on hematologic malignant patients infected with 2019 novel coronavirus. Arch Clin Infect Dis. 2020;15(3):e107788. doi: 10.5812/ archcid.107788.
Raman Sharma R. Fungal infections of the nervous system: current perspective and controversies in management. Int J Surg. 2010;8(8):591-601. doi: 10.1016/j.ijsu.2010.07.293.
Góralska K, Blaszkowska J, Dzikowiec M. Neuroinfections caused by fungi. Infection. 2018;46(4):443-59. doi: 10.1007/ s15010-018-1152-2.
McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150-60. doi: 10.1056/ NEJMra1216008.
Silva LN, de Mello TP, de Souza Ramos L, Branquinha MH, Roudbary M, Dos Santos ALS. Fungal infections in COVID-19-positive patients: a lack of optimal treatment options. Curr Top Med Chem. 2020;20(22):1951-7. doi: 10 .2174/156802662022200917110102.
Rabiei MM, Zali A, Rahmati Roodsari S, Arab-Mazar Z, Lotfali E. Candidiasis in COVID-19 patients. Nov Biomed. 2021;9(2):101-3. doi: 10.22037/nbm.v9i2.34133.
Bhatt K, Agolli A, Patel MH, Garimella R, Devi M, Garcia E, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova). 2021;9(1):e126. doi: 10.15190/d.2021.5.
Sarda R, Swain S, Ray A, Wig N. COVID-19-associated mucormycosis: an epidemic within a pandemic. QJM. 2021. doi: 10.1093/qjmed/hcab165.
- Abstract Viewed: 167 times
- PDF Downloaded: 232 times